Biotechnology
Enlivex to Raise $212 Million with Matteo Renzi Joining the Board
Enlivex, a Nasdaq-listed biotech company, aims to raise $212 million for investment in a decentralized prediction market token, appointing former Italian Prime Minister Matteo Renzi to its board for strategic guidance.

